Related Experiment Video
Updated: Jun 17, 2026
07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Cardiac support devices
Marnie Rodger1, Marion E McRae, Munira Jaffer
1Cardiovascular Surgery Service, Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, ON M5G 2N2, Canada. marnie.rodger@uhn.on.ca
Progress in Cardiovascular Nursing
|December 17, 2009
Summary
Heart failure, a common condition, involves progressive left ventricular enlargement. Surgical treatments, including cardiac support devices, offer new hope for improving survival and quality of life in patients.
Area of Science:
- Cardiology and Cardiac Surgery
- Medical Device Technology
Background:
- Heart failure (HF) is a prevalent and serious condition in the US, marked by high mortality and significant healthcare costs.
- HF is characterized by chronic, progressive left ventricular enlargement and dysfunction.
- Current medical therapies can slow but not reverse left ventricular remodeling.
Observation:
- Surgical interventions have emerged as crucial for enhancing survival and quality of life in HF patients.
- Cardiac support devices represent a novel therapeutic avenue for advanced heart failure.
- This review examines surgical procedures for left ventricular dysfunction, emphasizing cardiac support devices.
Findings:
- Surgical approaches, particularly cardiac support devices, offer improved outcomes for heart failure patients.
- The integration of cardiac support devices into treatment protocols is a key development in managing left ventricular dysfunction.
- Nursing care protocols are essential for successful patient management with these devices.
Implications:
- Cardiac support devices hold significant potential to transform heart failure management.
- Further research and clinical application of these devices can reduce mortality and improve patient well-being.
- Optimized nursing care is critical for the safe and effective use of cardiac support devices in heart failure patients.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...